The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling, PLoS Med, vol.13, p.1002152, 2016. ,
National policies on the management of latent tuberculosis infection: review of 98 countries, Bull World Health Organ, vol.96, pp.173-184, 2018. ,
The immune response in tuberculosis, Annu Rev Immunol, vol.31, pp.475-527, 2013. ,
Innate immunity in tuberculosis: host defense vs. pathogen evasion, Cell Mol Immunol, vol.14, pp.963-75, 2017. ,
The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria?, Clin Dev Immunol, p.139127, 2012. ,
Immunology of tuberculosis, Annu Rev Immunol, vol.19, pp.93-129, 2001. ,
The role of the granuloma in expansion and dissemination of early tuberculous infection, Cell, vol.136, pp.37-49, 2009. ,
Updates on the risk factors for latent tuberculosis reactivation and their managements, Emerg Microbes Infect, vol.5, p.10, 2016. ,
HIV-TB co-infection: mechanisms that drive reactivation of Mycobacterium tuberculosis in HIV infection, Oral Dis, pp.53-60, 2016. ,
The risk factors for tuberculosis in liver or kidney transplant recipients, BMC Infect Dis, vol.14, p.387, 2014. ,
Immunity to the dual threat of silica exposure and Mycobacterium tuberculosis, Front Immunol, vol.9, p.3069, 2018. ,
Risk and timing of tuberculosis among close contacts of persons with infectious tuberculosis, J Infect Dis, vol.218, pp.1000-1008, 2018. ,
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement, Eur Respir J, vol.36, pp.1185-206, 2010. ,
Tuberculosis and chronic renal disease, Semin Dial, vol.16, pp.38-44, 2003. ,
Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis, Infect Immun, vol.69, pp.1722-1730, 2001. ,
An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells, Cell Microbiol, vol.6, pp.423-456, 2004. ,
Foamy macrophages and the progression of the human tuberculosis granuloma, Nat Immunol, vol.10, pp.943-951, 2009. ,
Role of innate cytokines in mycobacterial infection, Mucosal Immunol, vol.4, pp.252-60, 2011. ,
Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture, J Bacteriol, vol.186, pp.5017-5047, 2004. ,
A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis, J Biol Chem, vol.281, pp.3866-75, 2006. ,
Experimental models of foamy macrophages and approaches for dissecting the mechanisms of lipid accumulation and consumption during dormancy and reactivation of tuberculosis, Front Cell Infect Microbiol, vol.6, p.122, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01455789
Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship, Clin Immunol Orlando Fla, vol.113, pp.130-136, 2004. ,
Interleukin-4-induced ?catenin regulates the conversion of macrophages to multinucleated giant cells, Mol Immunol, vol.54, pp.157-63, 2013. ,
Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion, Nat Med, vol.14, pp.81-88, 2008. ,
?1 and ?2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation, Am J Pathol, vol.160, issue.10, pp.64882-64883, 2002. ,
IL-10 modulates in vitro multinucleate giant cell formation in human tuberculosis, PLoS ONE, vol.8, p.77680, 2013. ,
Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity, Infect Immun, vol.74, pp.6108-6125, 2006. ,
Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks, J Immunol Baltim Md, vol.1950, pp.3565-73, 1997. ,
Langhans giant cells from M. tuberculosis-induced human granulomas cannot mediate mycobacterial uptake, J Pathol, vol.211, pp.76-85, 2007. ,
3D reconstruction of granulomas from transmitted light images implemented for longtime microscope applications, J Immunol Methods, vol.360, pp.10-19, 2010. ,
Granulomatous response to Coxiella burnetii, the agent of Q fever: the lessons from gene expression analysis, Front Cell Infect Microbiol, vol.4, p.172, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01771477
Impaired granuloma formation in sepsis: impact of monocytopenia, PLoS ONE, vol.11, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01466886
The use of NSAIDs in rheumatic disorders 2005: a global perspective, Inflammopharmacology, vol.13, pp.343-70, 2005. ,
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection, Lancet Infect Dis, vol.3, pp.578-90, 2003. ,
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection, Cell, vol.56, pp.731-771, 1989. ,
TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection, J Immunol, vol.168, pp.4620-4627, 2002. ,
Human granuloma in vitro model, for TB dormancy and resuscitation, PLoS ONE, vol.8, p.53657, 2013. ,
Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis, Expert Opin Drug Saf, vol.2, pp.347-65, 2003. ,
Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept, Drug Saf, vol.25, pp.173-97, 2002. ,
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent, N Engl J Med, vol.345, pp.1098-104, 2001. ,
Granulomatous infections due to tumor necrosis factor blockade: correction, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.39, pp.1254-1259, 2004. ,
Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?, Clin Infect Dis, vol.41, pp.199-203, 2005. ,
Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis, J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res, vol.34, pp.716-742, 2014. ,
Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model. mBio, vol.6, pp.2537-2551, 2015. ,
Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4, J Immunol Baltim Md, vol.1950, pp.3695-703, 2004. ,
Adalimumab: a review of its use in rheumatoid arthritis, BioDrugs Clin Immunother Biopharm Gene Ther, vol.18, pp.121-160, 2004. ,
Adalimumab therapy in rheumatoid arthritis, Rheum Dis Clin North Am, vol.30, pp.349-64, 2004. ,
Infliximab treatment for rheumatic disease: clinical and radiological efficacy, Ann Rheum Dis, pp.67-76, 2002. ,
Mast cell cytonemes as a defense mechanism against Coxiella burnetii, mBio, vol.10, pp.2669-2687, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02262531
Distinct roles for tetraspanins CD9, CD63, and CD81 in the formation of multinucleated giant cells, Immunology, vol.127, pp.237-285, 2009. ,
HIV-1 Nef triggers macrophage fusion in a p61Hck-and protease-dependent manner, J Immunol, vol.184, pp.7030-7039, 2010. ,
Vitamin D analogs differentially control antimicrobial peptide/"alarmin"expression in psoriasis, PLoS ONE, vol.4, p.6340, 2009. ,
Methylprednisolone prevents tumour necrosis factor-?-dependent multinucleated giant cell formation, Rheumatology, vol.49, pp.2037-2079, 2010. ,
Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-gamma and IL-4, J Immunol Baltim Md, vol.1950, pp.3002-3012, 1993. ,
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the threeyear prospective French Research Axed on Tolerance of Biotherapies registry, Arthritis Rheum, vol.60, pp.1884-94, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00400633
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice, Immunity, vol.2, pp.561-72, 1995. ,
How tumour necrosis factor blockers interfere with tuberculosis immunity, Clin Exp Immunol, vol.161, pp.1-9, 2010. ,
Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report, Arthritis Rheum, vol.52, pp.61-72, 2005. ,
Molecular mechanisms of action of anti-TNF-? agents -Comparison among therapeutic TNF-? antagonists, Cytokine, vol.101, pp.56-63, 2018. ,
Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept, Aliment Pharmacol Ther, vol.21, pp.251-259, 2005. ,
Rôle des inhibiteurs du TNF sur la formation in vitro de granulome, Rev Médecine Interne, vol.35, p.37, 2014. ,
Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis, Pulm Med, p.745483, 2012. ,
Mycobacterium tuberculosis infection and inflammation: what is beneficial for the host and for the bacterium? Front Microbiol, vol.2, 2011. ,
Interleukin-10 family and tuberculosis: an old story renewed, Int J Biol Sci, vol.12, pp.710-717, 2016. ,
Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression, Rheumatol Oxf Engl, vol.49, pp.2264-72, 2010. ,
TNF-? blockade induces IL-10 expression in human CD4 + T cells, Nat Commun, vol.5, p.3199, 2014. ,
TNF-?-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-? blockade-driven IL-17A expression, J Allergy Clin Immunol, vol.142, pp.517-546, 2018. ,
Pathophysiology of ANCA-associated small vessel vasculitis, Curr Rheumatol Rep, vol.12, pp.399-405, 2010. ,
IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection, J Immunol Baltim Md, vol.1950, pp.4662-4671, 2006. ,
Essential role of IL-17A in the formation of a mycobacterial infectioninduced granuloma in the lung, J Immunol Baltim Md, vol.1950, pp.4414-4436, 2010. ,
Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection, PLoS Pathog, vol.10, p.1004099, 2014. ,
Innate IL-17-producing cells: the sentinels of the immune system, Nat Rev Immunol, vol.10, pp.479-89, 2010. ,